Early results from the company’s single-arm trial saw the therapy able to partially repair the chemical responsible for ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to EXG-34217 for the treatment of telomere biology disorders.

本产品可以通过阴性分选法从人细胞样品中富集CD34+细胞。原理是利用生物素（biotin）标记的单克隆抗体对非目标细胞（非CD34+细胞）进行标记，然后通过链霉亲和素（streptavidin）标记的磁珠对非目标细胞进行清除，从而达到富集CD34+细胞的目的。分选过程需要用 ...

Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation. Leukemia. 2025;1-11.

Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of ...

Data published in NEJM Evidence detail the first clinical test of ZSCAN4 for telomere elongation.Treatment with EXG-34217 resulted in in vivo ...

为解决脂肪移植留存率难以控制的问题，第四军医大学的研究人员开展了关于筋膜来源干细胞（FDSCs）提升脂肪移植留存率的研究，结果发现 FDSCs 能有效促进血管生成、提高移植留存率，为组织修复和再生提供了新策略。

Taking prescribed beta blockers during hematopoietic stem cell transplantation may increase mortality risk due to suppression ...

present an important study that applied a high-resolution transposon-based barcoding system to show the clonal contribution of hematopoietic stem and ...

血液系统疾病的MICM综合诊断协同各个方面的信息，打破单一诊断方法的局限性，最大程度地减少误诊与漏诊，为患者制定最适宜的治疗方案提供可靠依据。在医疗科学持续进步的征程中，MICM指引着我们朝着更精准、更有效的血液系统疾病诊疗方向大步迈进，给予患者更多 ...

为探究高原动物心脏适应机制，研究人员开展牦牛心脏中 Telocytes（TCs）的研究。结果发现其在主动脉球和心肌的分布、特征等。该研究为揭示高原动物适应环境的奥秘提供关键线索，值得科研读者一读。

Tremtelectogene empogeditemcel (trem-cel) may make gemtuzumab ozogamicin maintenance safer for patients with high-risk acute myeloid leukemia (AML), according to results of a phase 1/2 trial presented ...